Views

CrossRef citations to date

Altmetric

Letters to the Editor

Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes

Stephan R. BohlDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Anna DolnikDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Thomas JensenMedical Prognosis Institute (MPI), Hørsholm, Denmark;

Katharina M. LangDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Björn HackansonDepartment of Internal Medicine I, University of Freiburg Faculty of Medicine, Freiburg, Germany

Verena I. GaidzikDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Peter PaschkaDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Steen KnudsenMedical Prognosis Institute (MPI), Hørsholm, Denmark;

Konstanze DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Hartmut DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany;

Rainer ClausDepartment of Internal Medicine I, University of Freiburg Faculty of Medicine, Freiburg, Germany

Michael LübbertDepartment of Internal Medicine I, University of Freiburg Faculty of Medicine, Freiburg, Germany

Lars BullingerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors thank all members of the German-Austrian AML Study Group (AMLSG) for their participation in this study and for providing patient samples. This study was supported in part by the Deutsche Krebshilfe (DKH 110530), and LB was supported in part by the Deutsche Forschungsgemeinschaft (Heisenberg-Professur BU 1339/8-1) and ML is supported by the Deutsche Forschungsgemeinschaft (SPP1463, SFB992-Medep).

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1287360.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes

Information for

Open access

Opportunities

Help and information

Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes

Acknowledgements

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature